164 related articles for article (PubMed ID: 2465485)
1. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
[TBL] [Abstract][Full Text] [Related]
2. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
[TBL] [Abstract][Full Text] [Related]
3. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
McHugh MM; Sigmund RD; Beerman TA
Biochem Pharmacol; 1990 Feb; 39(4):707-14. PubMed ID: 1689578
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
Poot M; Hiller KH; Heimpel S; Hoehn H
Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
[TBL] [Abstract][Full Text] [Related]
6. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
Woynarowski JM; Sigmund RD; Beerman TA
Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776
[TBL] [Abstract][Full Text] [Related]
7. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Fesen M; Pommier Y
J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
[TBL] [Abstract][Full Text] [Related]
8. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
Bell A; Kittler L; Löber G; Zimmer C
J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
[TBL] [Abstract][Full Text] [Related]
9. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
Yamamoto K; Kawanishi S
Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
[TBL] [Abstract][Full Text] [Related]
10. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
Smith PJ; Bell SM; Dee A; Sykes H
Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
[TBL] [Abstract][Full Text] [Related]
11. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases.
Bartulewicz D; Bielawski K; Bielawska A
Arch Pharm (Weinheim); 2002 Nov; 335(9):422-6. PubMed ID: 12447915
[TBL] [Abstract][Full Text] [Related]
12. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
13. Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
Mortensen UH; Stevnsner T; Krogh S; Olesen K; Westergaard O; Bonven BJ
Nucleic Acids Res; 1990 Apr; 18(8):1983-9. PubMed ID: 2159632
[TBL] [Abstract][Full Text] [Related]
14. Molecular recognition of B-DNA by Hoechst 33258.
Harshman KD; Dervan PB
Nucleic Acids Res; 1985 Jul; 13(13):4825-35. PubMed ID: 2410856
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
[TBL] [Abstract][Full Text] [Related]
17. Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives.
Bailly C; Dassonneville L; Carrasco C; Lucas D; Kumar A; Boykin DW; Wilson WD
Anticancer Drug Des; 1999 Feb; 14(1):47-60. PubMed ID: 10363027
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
19. Structural modifications induced in Chinese hamster V79--E chromosomes by prefixation treatment in vitro with the AT-specific agents netropsin, distamycin A, and Hoechst 33258.
Thust R; Rønne M
Hereditas; 1981; 94(2):209-13. PubMed ID: 6170606
[No Abstract] [Full Text] [Related]
20. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
